NO991244D0 - Use of antiflogistics in inhibiting viral infections - Google Patents

Use of antiflogistics in inhibiting viral infections

Info

Publication number
NO991244D0
NO991244D0 NO991244A NO991244A NO991244D0 NO 991244 D0 NO991244 D0 NO 991244D0 NO 991244 A NO991244 A NO 991244A NO 991244 A NO991244 A NO 991244A NO 991244 D0 NO991244 D0 NO 991244D0
Authority
NO
Norway
Prior art keywords
antiflogistics
viral infections
inhibiting viral
inhibiting
infections
Prior art date
Application number
NO991244A
Other languages
Norwegian (no)
Inventor
Toril Garatun Krogdal
Original Assignee
Toril Garatun Krogdal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toril Garatun Krogdal filed Critical Toril Garatun Krogdal
Priority to NO991244A priority Critical patent/NO991244D0/en
Publication of NO991244D0 publication Critical patent/NO991244D0/en
Priority to PCT/NO2000/000086 priority patent/WO2000054771A1/en
Priority to AU34657/00A priority patent/AU3465700A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO991244A 1999-03-12 1999-03-12 Use of antiflogistics in inhibiting viral infections NO991244D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO991244A NO991244D0 (en) 1999-03-12 1999-03-12 Use of antiflogistics in inhibiting viral infections
PCT/NO2000/000086 WO2000054771A1 (en) 1999-03-12 2000-03-10 The use of 3,5-pyrazolidinedione derivatives to combat viral infections
AU34657/00A AU3465700A (en) 1999-03-12 2000-03-10 The use of 3,5-pyrazolidinedione derivatives to combat viral infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO991244A NO991244D0 (en) 1999-03-12 1999-03-12 Use of antiflogistics in inhibiting viral infections

Publications (1)

Publication Number Publication Date
NO991244D0 true NO991244D0 (en) 1999-03-12

Family

ID=19903083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991244A NO991244D0 (en) 1999-03-12 1999-03-12 Use of antiflogistics in inhibiting viral infections

Country Status (3)

Country Link
AU (1) AU3465700A (en)
NO (1) NO991244D0 (en)
WO (1) WO2000054771A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593703B1 (en) * 1986-02-04 1990-07-20 Miesch Jean Olivier APPLICATION OF BUTYL-4-DIPHENYL-1,2-PYRAZOLIDINE-DIONE-3,5 AS ANTIVIRAL AGENT IN HUMANS OR ANIMALS
JPH0610141B2 (en) * 1986-02-14 1994-02-09 新技術事業団 AIDS viral disease treatment agent

Also Published As

Publication number Publication date
AU3465700A (en) 2000-10-04
WO2000054771A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
IS6256A (en) Combinations against viruses
ID26056A (en) DIAPON ONCE USE
AP2001002301A0 (en) Inhibition of viral infection using monovalentantigen-binding proteins
DE60033450D1 (en) Hand access port
ID26389A (en) DIAPON ONCE USE
ID30590A (en) ONCE USE SHORT TYPE OF SHORT-PANTS
NO20022419D0 (en) Infectious clones
AR028281A1 (en) DERIVATIVES OF 2- (ARILALQUILAMINO) PIRIMIDONA AND DERIVATIVES OF 2- (HETEROAROARILALQUILAMINO) PIRIMIDONA
NO20021301D0 (en) Use of CSAIDS in rhinovirus infection
NO20030239D0 (en) Modified virus
PT1207757E (en) FORMULACS OF SPINOSINS IN SUSPENSION AQUOSA ECTOPARASITICIDAS
FI19991925A (en) Pharmaceutical solutions of levosimendan
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
ID25571A (en) DIAPON ONCE USE
NO20022816D0 (en) Treatment of viral infections using levovirin
GB0024442D0 (en) Genetic factors affecting the outcome of viral infections
AU9279601A (en) Compounds and methods for use thereof in the treatment of cancer or viral infections
PT1220858E (en) OXAZINOQUINOLONES UTEIS FOR THE TREATMENT OF VIRAL INFECTIONS
NO20032769D0 (en) Combination method for the treatment of viral infections
GB9930061D0 (en) Quinolone compounds for use in treating viral infections
AP2002002432A0 (en) Treatment of viral infections
NO991244D0 (en) Use of antiflogistics in inhibiting viral infections
NO20003829D0 (en) Refinement improvements
ID30381A (en) USE OF ARILALKANOILPIRIDAZINA
NO20030201D0 (en) Use of IL-8 receptor antagonists in the treatment of viral infections